EGFR and neoplasm: In contrast, ursodeoxycholic acid (UDCA) exerts antagonistic effects: it not only downregulates EGFR expression and suppresses EMT (41, 42), but also inhibits tumor metastasis by enhancing epithelial cadherin expression.